Chronic Kidney Disease

A retrospective cohort study published in Kidney Medicine identified an association between higher BMI and a greater risk of developing “a low serum bicarbonate,” an identifier for metabolic acidosis.

Applying a risk progression classification system to patients with a sepsis-associated kidney injury can aid nephrologists in predicting long-term kidney outcomes, results show.

Results of a survey administered to nephrology and palliative care clinicians revealed both groups view a lack of coordination as the primary obstacle to integrating effective end-of-life care into chronic kidney disease care.

A study analyzing behavior modification interventions for chronic kidney disease found the intervention to be cost-effective and a justifiable use of health care resources.

Rapid weight gain and loss are linked with a high risk of adverse outcomes in patients with chronic kidney disease, according to a study.

Between 2007 and 2016, researchers observed that use of metformin and newer glucose-lowering medications increased significantly for patients with chronic kidney disease and type 2 diabetes.

Blue Cross and Blue Shield of Minnesota announced it will partner with DaVita Inc. to launch its integrated kidney care VillageHealth program in the Blue Cross Minnesota network.

Patients with chronic kidney disease who resided in the inner-city expressed similar hesitancy to the COVID-19 vaccine as patients who attended family medicine clinics in the same area, according to a study presented here.

Although most insurance providers, including Medicare and private insurers, cover medical nutrition therapy for individuals with chronic kidney disease, few patients ever meet with a registered dietician.

Among patients with chronic kidney disease, use of in-person services was dramatically reduced during the early months of COVID-19 pandemic, which was followed by an incomplete rebound, according to presented data.